Filing Details
- Accession Number:
- 0000950170-24-009495
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-31 17:30:13
- Reporting Period:
- 2024-01-29
- Accepted Time:
- 2024-01-31 17:30:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1422143 | Kura Oncology Inc. | KURA | Pharmaceutical Preparations (2834) | 611547851 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1813058 | Brophy Teresa Bair | C/O Kura Oncology, Inc. 12730 High Bluff Drive, Suite 400 San Diego CA 92130 | Chief Legal Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-01-29 | 2,053 | $17.80 | 68,979 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/23.
Billionaire Hedge Funds
